ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

A1LN34 Alnylam Pharmaceuticals Inc

38.30
0.00 (0.00%)
May 23 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 3.33B3.54B3.55B3.39B3.4B3.84B3.83B3.82B
Total Current Assets 2.47B2.69B2.69B2.54B2.52B2.99B2.98B2.99B
Cash and Equivalents 575.56M1.07B866.39M672.25M657.8M1.03B812.69M681.88M
Total Non-Current Assets 858.78M1.36B1.38B850.92M878.35M853.62M1.37B835.78M
Total Liabilities 3.15B3.6B3.7B3.65B3.81B4B4.05B4.04B
Total Current Liabilities 657.69M772.79M767.92M673.39M788.64M949.79M967.79M941.71M
Total Non-Current Liabilities 3.17B3.85B3.95B4B4.04B4.07B4.1B4.12B
Common Equity 1.21M1.23M1.24M1.24M1.25M1.26M1.26M1.27M
Retained Earnings -5.96B-6.36B-6.57B-6.74B-7.02B-6.87B-7.01B-7.08B
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 1.26B1.99B1.57B2.4B3.41B3.64B3.55B3.83B
Total Current Assets 671.88M1.76B1.2B1.72B2.61B2.81B2.69B2.98B
Cash and Equivalents 193.62M645.36M420.15M547.18M496.58M819.98M866.39M812.69M
Total Non-Current Assets 920.22M1.77B1.3B1.44B1.02B588.2M-158.22M-220.64M
Total Liabilities 342.59M228.3M272.84M956.44M2.39B3.06B3.7B4.05B
Total Current Liabilities 131.7M144.25M179.49M352.59M585.27M695.71M767.92M967.79M
Total Non-Current Liabilities 360.89M114.05M123.34M603.85M2B3.04B3.95B4.1B
Total Equity 920.22M1.77B1.3B1.44B1.02B588.2M-158.22M-220.64M
Common Equity 859k997k1.01M1.12M1.16M1.2M1.24M1.26M
Retained Earnings -1.66B-2.15B-2.84B-3.73B-4.59B-5.44B-6.57B-7.01B